Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) proteins of the Natural Bovine Bone Matrix (NBBM) scaffold and autologous grafts represent a complex assembly of structural and bioactive molecules essential for bone regeneration. These proteins, primarily including Type I collagen, osteocalcin, and bone sialoprotein, provide the necessary architecture and biochemical cues for osteoblast adhesion, proliferation, and differentiation (UniProt: P02452; PubMed: 32824342). In clinical practice, NBBM serves as an osteoconductive scaffold that maintains space and supports new bone formation in dental and orthopedic procedures, such as ridge augmentation and sinus lifts. Autologous grafts complement this by providing osteoinductive growth factors, such as bone morphogenetic proteins (BMPs), and living osteogenic cells, which significantly enhance the overall regenerative potential compared to synthetic alternatives (StatPearls: NBK537071). While not a single drug target, these proteins interact with cellular receptors like integrins to trigger intracellular signaling pathways conducive to tissue repair. Understanding the composition of these matrices is crucial for optimizing bone grafting outcomes and developing next-generation biomimetic scaffolds in the field of regenerative medicine.
Provides an osteoconductive framework and biochemical signals that facilitate the attachment, migration, and differentiation of osteogenic cells through integrin-mediated signaling (Bousnaki et al., 2020; PubMed: 32824342).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix protein of the natural bovine bone matrix scaffold and autologous graft (ECM protein (NBBM/Autograft)).